Particle therapy is one of the most popular alternative treatment procedures for radiation therapy. With particle therapy systems, precise delivery of the radiation dose to the required tumor site is possible.
Market growth is driven by factors such as growing adoption of particle therapy in clinical trials and the increasing number of particle therapy centers worldwide. Emerging markets are China India, Brazil, and South Africa are showing lucrative growth opportunities to market.
The particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027.
To know about the assumptions considered for the study download the pdf brochure
Prominent players in the particle therapy market include Varian Medical Systems, Inc. (US), IBA Worldwide (EU), Mevion Medical Systems (US), Provision Healthcare, LLC (US), Sumitomo Heavy Industries, Ltd. (Japan), Hitachi, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), Protom International, Inc. (US), Advanced Oncotherapy PLC. (EU), and Danfysik A/S (Denmark)
IBA Worldwide (EU)
IBA is one of the leading players in the particle therapy market. Its Proton Therapy segment offers Proteus PLUS, a treatment room solution, and Proteus ONE, a single-room cancer treatment solution. IBA caters its products to various end users, including hospitals and ambulatory radiotherapy centers. The firm focuses on strengthening its market position by adopting both organic (such as product development and approvals) as well as inorganic growth strategies (such as agreements, collaborations, and partnerships). During the last three years, the company has significantly invested in R&D activities.
Varian Medical Systems, Inc. (US)
Varian Medical Systems is one of the leading providers of particle therapy systems across the globe. The company offers excellent sales and support services, such as equipment installation and custom service. With its strong product portfolio and wide geographic presence, the company is expected to grow at a high rate in the proton therapy market. The company focuses on both organic and inorganic growth strategies to enhance its footprint in the global market. In the past three years, the company received approvals from various regulatory bodies to introduce its proton therapy products across various regions. The company is also focused on providing training and conducting workshops.
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) - Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE